Programmed cell death ligand 1 mRNA and protein expression and lymphocytic infiltrate were greater in functioning pituitary adenomas than in clinically nonfunctioning adenomas (hormone-negative adenomas and SGAs) (57), providing a theoretical rationale for checkpoint inhibitor treatment of these tumors. This evidence concerns the gene CD274 and adenoma.